رقم الجزء
تجريد
صلاحيه
UOM
NIIN
معلومات الجزء
Cyclophosphamide for injection usp 200mg vial 12s pg
TXT
وصف:
U Cyclophosphamide For Injection
MRC:
The recognized shape,configuration,structure,or mold of a substance,natural or refined,that most nearly corresponds to the appearance of the item.AGXW
Physical Form:
Powder
MRC:
The peculiar storage feature/s/ required for an item in order to provide the degree of protection necessary to maintain serviceability standards.AJCN
Protective Storage Feature:
Antineoplastic drug
MRC:
The ingredients compounded in a pharmaceutical preparation and recognized as having therapeutic value/s/. /usually representative in the item name generic nomenclature./AKJA
Active Medicament Medicinal Strength:
200.000 mg anhydrous cyclophosphamide active ingredient
MRC:
Those features,not otherwise specified,which may be required for proper functioning of the item.CBBL
Features Provided:
Sterile
MRC:
Indicates the type of container/s/ or supporting device/s/ which is in direct contact with the item.CQCT
Primary Container Type:
Vial
MRC:
The statements required to be included on the label of drugs subject to provisions of the federal food,drug,and cosmetic act.CQPQ
Err Default:
Err default
MRC:
The statements required to be included on the label of drugs subject to provisions of the federal food,drug,and cosmetic act.CQPQ
Warning And Caution Statements:
Chemotherapeutic agent; handle with care
MRC:
A numeric value of the volume,form,or dosage within each primary container.CRLK
Primary Container Content Quantity:
200.000 milligrams active ingredient
MRC:
The number of primary containers within the item of supply.CSCW
Total Primary Container Quantity:
12
MRC:
Those unusual or unique characteristics or qualities of an item not covered in the other requirements and which are determined to be essential for identification.FEAT
Special Features:
Vial w/not less than 15 ml of volume; note: d
MRC:
An indication of the same predictable therapeutic effect as determined by the food and drug administration (fda) for an item of supply when administered under the conditions as specified in the labeling.THPE
Therapeutic Equivalent:
Neosar by adria labs., inc.; cytoxan by bristol labs., inc.
